• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Video

Educational and Unmet Needs in GPP Management

Author(s):

David Kaplan, MD

An expert in dermatology shares his thoughts on the educational and unmet needs in the identification and management of patients with GPP.

Current Time 0:00
Duration 3:48
Loaded: 0%
Stream Type LIVE
Remaining Time 3:48
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Related Videos
    Pipeline Updates on the Horizon From Arcutis Biotherapeutics
    Pipeline Updates on the Horizon From Arcutis Biotherapeutics
    LaShell Robinson on Takeda’s Initiative to Improve Research Diversity
    LaShell Robinson on Takeda’s Initiative to Improve Research Diversity
    Efficient Screening for Psoriatic Arthritis
    Efficient Screening for Psoriatic Arthritis
    Jeff Stark, MD: Enhancing Flexibility and Personalized Treatment with 320 mg Bimekizumab Dosage
    Jeff Stark, MD: Enhancing Flexibility and Personalized Treatment with 320 mg Bimekizumab Dosage
    4 KOLs are featured on this panel.
    Updating Treatment Guidelines: Incorporating Novel Therapies to Address Unmet Needs
    4 KOLs are featured on this panel.
    When to Discontinue Treatment: Interpreting Safety Signals and Adverse Event Patterns
    4 KOLs are featured on this panel.
    Achieving Durable Responses: Physician's Guide to Interpreting Long-Term Efficacy Data
    4 KOLs are featured on this panel.
    Long-Term Efficacy and Insights from POETYK PSO-1 Studies: Implications for Psoriasis Treatment
    Omar Noor, MD, FAAD, is featured in this series.
    Tapinarof Spotlight: Non-Steroidal Topical for Extended Relief in Plaque Psoriasis
    Omar Noor, MD, FAAD, is featured in this series.
    Topical Treatments for Psoriasis: Addressing Adverse Events and Skin of Color Considerations
    Related Content
    Takeda Targets Clinical Disparities in Psoriasis Research
    March 5th 2025

    Takeda Targets Clinical Disparities in Psoriasis Research

    The Cutaneous Connection: An Inside Look of the Inclusive Atlas
    November 4th 2021

    The Cutaneous Connection: An Inside Look of the Inclusive Atlas

    A “Step-Down” Approach May Be More Effective for Younger Patients with Psoriasis
    February 27th 2025

    A “Step-Down” Approach May Be More Effective for Younger Patients with Psoriasis

    The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
    September 23rd 2021

    The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

    Nail Diseases in Skin of Color: A Research Gap
    February 20th 2025

    Nail Diseases in Skin of Color: A Research Gap

    5-Year Study Backs Deucravacitinib’s Safety and Efficacy
    February 19th 2025

    5-Year Study Backs Deucravacitinib’s Safety and Efficacy

    © 2025 MJH Life Sciences

    All rights reserved.